Home / Transcripts / TOYO Co., Ltd. (TOYO) · November 16, 2026

TOYO Co., Ltd. (TOYO) Earnings Call Transcript

November 16, 2026

NASDAQ US Information Technology Semiconductors and Semiconductor Equipment earnings

Earnings Call Speaker Segments

Crocker Coulson executive
#1

Thanks, Matt. Hi, everybody. We really appreciate you being here as we go through TOYO's results for the third quarter and the first nine months of 2026; earlier today, TOYO put out both the earnings release and an investor presentation related to it on our website, and you'll find those at investors.toyo-solar.com. Joining us on this call today are Takahiko Onozuka, TOYO's Chairman and Chief Executive Officer; Rhone Resch, TOYO's Chief Strategy Officer; and Yasunari Harada, TOYO's Chief Financial Officer. Simon Shi, Senior Advisor to the Board, is also with us and will be around for the Q&A part of this call. Once their prepared remarks wrap up, we'll open the line for your questions. Before we get started, the financial results we'll be discussing on this call for the third quarter of 2026 and the first nine months of 2026, along with the corresponding periods of 2025, are unaudited, and certain statements in this teleconference are forward-looking within the meaning of federal securities laws; among them are statements regarding our module business outlook, expected solar module deliveries and solar cells supply, the resumption of sales to U.S. customers, our HJT cell line, the Section 232 program and our discussions with Department of Commerce, and the Commerce circumvention inquiry. While we believe these statements are reasonable, we can give no assurance that they will ultimately turn out to be accurate, since they are prospective in nature. On this call, we'll also discuss certain non-GAAP financial measures, including adjusted EBITDA and adjusted net income. Reconciliations to the most directly comparable GAAP measures are included in our earnings release. Actual results could differ materially from those we discuss today. So we encourage you to review our most recent annual report on Form 20-F, Form 6-K, and other SEC filings for risk factors that could materially impact our results; with those formalities out of the way, it's now my great pleasure to turn this call over to Onozuka-san, TOYO's Chairman and CEO. Onozuka-san, please take it away.

Takahiko Onozuka executive
#2

Thank you, Crocker. During the third quarter, U.S. trade proceedings involving solar cells from our Ethiopia facility caused disruption to our cell business. In spite of that, we stayed profitable, third-quarter revenue rose 57.3% compared with a year earlier, and our U.S. module business kept growing. Across the first nine months, revenue grew 42.0%, and net income almost doubled. We achieved genuine operational progress as well. We finished our second module line in Humble, Texas, lifting capacity at that site to roughly 2 gigawatts, and we reached a milestone with our October 6 ribbon-cutting and Solar Analyst Day. Rhone will walk you through our trade proceeding and U.S. module business, and our CFO, Harada-san, will go over the financials in detail; we stay dedicated to full transparency across our supply chain and to establishing a long-term manufacturing platform in the United States. I'll now hand the call over to our CSO, Rhone Resch.

Rhone Resch executive
#3

Thank you, Onozuka-san, and good morning to all of you. My remarks will cover four topics that sit at the heart of TOYO's strategy in the United States: ongoing expansion of our U.S. module business, the Section 232 process, the HJT cell investment we have planned for Texas, and the trade proceedings that affect cells made in Ethiopia. Considered together, these developments demonstrate how TOYO is carrying out a clear strategy: growing U.S. manufacturing, constructing a non-FEOC supply chain that is more transparent and more resilient, and lowering our exposure to the trade uncertainty surrounding imported solar products. The opportunity in front of us is significant. Demand for solar products manufactured domestically keeps getting stronger, U.S. policy is providing increasing support for onshore production, and TOYO is positioning itself to take part in that transition at scale. I'll start with our U.S. module business, which remains an important source of growth and is increasingly giving us greater visibility into future revenue. As Onozuka-san noted, on October 6 we hosted a ribbon-cutting ceremony and Solar Analyst Day at our Houston-area facility in Humble, Texas, which marked completion of our expansion to roughly 2 gigawatts of module manufacturing capacity. We were honored to have with us Jeffrey Kessler, Under Secretary of Commerce for Industry and Security; Takeshi Koyama, Consul-General of Japan in Houston; Congressman Christian Menefee; and Paul Wormser of CEA Intertek, together with customers, partners, analysts, and investors. It was genuinely a fun event. For TOYO, this expansion marks an important milestone. We now operate a meaningful U.S. manufacturing platform at scale, backed by a growing workforce, strong customer demand, and continuing engagement with federal, state, and local stakeholders. Our U.S. module business keeps expanding. In the third quarter, we delivered 277.4 megawatts of modules during the quarter and 469 megawatts during the first nine months of the year. With our second production line now finished, our Houston-area module facility holds approximately 2 gigawatts of nameplate capacity. Importantly, customer demand is turning into contracted business. Since mid-June, we have signed multiple binding module supply agreements with U.S. customers totaling an aggregate value of approximately $240 million. Deliveries started in the third quarter and are set to run through the first half of 2027. This gives us meaningful visibility into our U.S. module business as we head into 2027. We have also taken steps to shield these customer commitments from the trade uncertainty affecting our Ethiopian cell operations. We have secured non-FEOC cell supplies from outside Ethiopia in amounts sufficient to support our committed U.S. module deliveries through 2027. That point matters for investors. While the trade proceedings have created uncertainty for our cell business, they have not halted the continued ramp of our U.S. module operations or our ability to meet committed customer deliveries. As I said, demand for U.S. modules backed by a transparent, non-FEOC supply chain remains strong, and that is precisely the manufacturing platform we are building in Texas. Now on trade policy: on August 6, the President signed a Section 232 proclamation that covers imports of polysilicon as well as downstream solar products. In our view, that step underscores how important it is to build a stronger domestic base for solar manufacturing, and it lines up closely with TOYO's long-term strategy in the United States. TOYO has filed a proposal with the Department of Commerce for an offset agreement meant to back our multi-year U.S. investment plan, including the HJT facility we have planned and the possible expansion of our U.S. manufacturing footprint into upstream solar products. Right now we are in discussions with Commerce about the terms of that proposal. Any agreement, including which products are eligible, volumes, timing, and other conditions, is still subject to Commerce's approval, so at this stage we cannot quantify what the potential financial impact might be. Still, the strategic objective is clear: we want TOYO's substantial U.S. manufacturing investment to line up with U.S. trade policy in a way that speeds up domestic production and strengthens the U.S. solar supply chain. Sourcing polysilicon is an important piece of that strategy; for products serving the U.S. market, all of the polysilicon we currently source comes from non-Chinese suppliers, including suppliers in the United States and OCI in Malaysia. Polysilicon produced in the U.S. accounts for the majority of what we use at our Ethiopian cell plant; that supports our broader goal of building a supply chain increasingly anchored in the United States and with allied countries. Our next major step in that strategy is manufacturing solar cells domestically. We are continuing to develop a 1.5 gigawatt heterojunction, or HJT, solar cell line at our Houston-area site in Humble, Texas. The planned investment comes to approximately $357 million, and we still expect pilot production no later than the first quarter of 2028. We understand that investors will naturally focus on the capital requirements that come with a project of this scale. The timing and pace of the investment will stay aligned with non-dilutive financing, availability, and other capital resources; we plan to pursue the project in a disciplined way while keeping appropriate liquidity for our existing operations. Strategically, this facility matters a great deal to TOYO. It will bring next-generation cell manufacturing and R&D onto the same U.S. campus as our module operations and further cut our reliance on imported cells. It is also a central piece of the broader U.S. manufacturing plan that we are discussing with the Department of Commerce. Our objective is not simply to assemble modules in the United States. Over time, we intend to build a more integrated U.S. manufacturing platform around advanced solar technology. Let me now turn to the trade proceedings affecting our Ethiopian operations. During the third quarter, shipments of solar cells from our Ethiopian facility were affected by a U.S. Customs and Border Protection examination; we worked closely and cooperatively with CBP and provided detailed information about our supply chain. I'm glad to say that every shipment held up by that examination has now been released, and we're working toward certification under CBP's Customs Trade Partnership Against Terrorism, or C-TPAT, a program that makes our supply chain even more secure and transparent. Still, getting those shipments released doesn't settle the separate U.S. Department of Commerce circumvention inquiry about solar cells completed in Ethiopia, which began on July 17th of this year and is still going on. Our U.S. module operations stay protected. As I said earlier, we've lined up non-FEOC cell supply from outside Ethiopia in an amount sufficient for our committed U.S. module deliveries through 2027, and that lets us keep serving our U.S. customers while the Commerce process moves ahead. Now I'd like to spend a little time on the anti-circumvention inquiry. As I noted, on July 17th the Department of Commerce opened a countrywide circumvention inquiry regarding certain solar cells and modules completed in Ethiopia that use parts or components from China. Fortunately, Commerce picked TOYO as a mandatory respondent, and we've filed our initial questionnaire response; that filing lays out detailed information about our sourcing, our investment, our manufacturing operations, and the value added through our production process in Ethiopia. We're cooperating fully with Commerce and will keep supplying all the information required as part of its review. One important fact in TOYO's case is that we don't use Chinese-origin wafers in our Ethiopian cell production. Chinese-origin wafers and other Chinese components played a significant role in prior solar circumvention proceedings, which makes our wafer sourcing an important distinction in the factual record. In the end, Commerce will weigh the complete record, and we can't predict either the outcome or the timing of the inquiry; we remain confident in the facts supporting TOYO's supply chain and will keep working constructively with Commerce throughout the process. Looking ahead, our priorities are clear: deliver on our contracted U.S. module business, keep supply chains transparent and traceable, manage trade risk carefully, and keep expanding advanced manufacturing in the United States. Even with the trade uncertainty affecting our cell business, we're building a larger, more diversified, and increasingly U.S.-based manufacturing platform; we believe that positions TOYO well for the direction in which both the market and U.S. policy are moving. I'll now hand the call over to our CFO, Yasunari Harada, to review our financial results in more detail. Harada-san?

Yasunari Harada executive
#4

Thanks, Rhone. For the third quarter, revenue came in at $129.0 million, which is 4.8% below the $135.6 million we posted a year earlier and 9.2% above the second quarter of 2026. Looking at products, cell sales reached $49.4 million, module sales were $55.4 million, and wafer sales, which started in July, contributed $24.3 million. Third-party revenue rose 57.3% to $112.1 million, while related-party revenues totaled $17.0 million. Cost of revenues came to $107.6 million, higher than the $100.8 million before. Gross profit was $21.5 million, giving a gross margin of 16.6%, versus 25.7% a year earlier and 31.3% in the second quarter. The gross margin decline was driven mainly by a shift in our sales mix, with solar cell sales falling and solar module sales rising. Our solar module business kept delivering a double-digit gross margin. Income tax expense was $0.6 million, lower than $5.8 million, which reflected reduced taxable income and the preferential 5% rate for our Singapore subsidiary that took effect June 1st, 2026. Net income reached $4.3 million, compared with $22.6 million a year earlier. Non-GAAP adjusted EBITDA was $19.5 million, and adjusted net income came to $4.5 million. Basic and diluted EPS were $0.10, versus $0.66. Now looking at the first nine months of 2026, revenue totaled $390.0 million, a 42.0% increase from $274.7 million a year earlier. That growth was driven mainly by module sales of $101.2 million, OEM service revenue of $37.2 million, and the new wafer sales, partially offset by lower cell sales. Gross profit was $106.2 million, up 83.4% from $57.9 million, for a gross margin of 27.2%, compared with 21.1% a year earlier. Operating expenses were $42.1 million, versus $19.5 million, reflecting added staff at our Ethiopia and Texas plants as well as higher legal and professional fees tied to trade and regulatory matters. Net income was $50.1 million, up 99.5% from $25.1 million. Non-GAAP adjusted EBITDA was $102.1 million, and adjusted net income was $50.7 million. Basic EPS was $1.27 and diluted EPS was $1.26, compared with $0.66 a year earlier. On the balance sheet, we finished the quarter with $74.0 million in cash and restricted cash, including $64.9 million of unrestricted cash, up from $58.9 million at year-end. Operating cash flow for the nine months was $35.2 million, and we invested $44.1 million in property and equipment. With our Houston solar module capacity substantially committed for 2027, we expect our Texas solar module operation to run at or near full capacity next year. Because of the continuing uncertainty around the Commerce circumvention inquiry and the Section 232 program, which mainly affect cell shipments, we are not giving quarterly guidance for our solar cell business or specific guidance on revenue, net income, or other metrics at this time. That wraps up the financial review. Thank you.

Crocker Coulson executive
#5

Operator, I think we're ready for the question-and-answer session.

Amit Dayal analyst
#6

Thanks. Morning, all, and congratulations on what was a fairly strong quarter even with some of those export control problems you're working through. One thing I'd ask on that subject: is there a particular kind of determination the CBP might issue that would let you move past this overhang somewhat, or are you simply working through the process while the CBP carries out its own diligence on it? How should we view the way this could get settled for you as we head into 2027?

Crocker Coulson executive
#7

Simon, why don't you handle that one, and perhaps draw a distinction between CBP and the circumvention so the listeners have it clear.

Rhone Resch executive
#8

Exactly. Thanks, Crocker. Good morning, Amit. The CBP process is pretty simple — they're checking whether forced labor played any part in making solar cells. Most companies bringing goods into the United States go through it, and it takes time. Obviously you need to produce information showing not just your own supply chain but also that of your suppliers, your polysilicon suppliers — details going all the way back to the place where the quartzite was actually mined, right? A lot of different parties in this process supply information to CBP. It does take a bit of time, but obviously we have a very close relationship with our polysilicon providers. They've been through this process before. Everything was handed over to CBP. We've had several meetings with them — some face-to-face, some over Zoom — and we've been fully open and transparent about whatever information they requested. I'd say we've built a very clear channel of communication. Our company has strong controls in place. We're quite disciplined when it comes to tracking our entire supply chain and keeping the details accessible; in this instance, we supplied that to them. Every detention we had has now been released by CBP. Again, this is ongoing — we'll continue giving them whatever information they need — but at this point there are no detentions. As I mentioned, we are in the process of applying for C-TPAT. The standard is pretty demanding. Not many U.S. solar producers hold it, but we've made the commitment. And that C-TPAT effort, again, reflects the company's dedication to both openness and regulatory adherence—and beyond that, it gives you, shall we say, a distinct certification status with CBP once you get through it. We're strongly dedicated as a business to keep collaborating with CBP and, naturally, to keep that data accessible. Then there's the circumvention matter—a separate thing entirely. A coalition of companies headed by First Solar brought that case, and it kicked off on July 17th. So the circumvention case follows the standard process in which the Department of Commerce issues a questionnaire to mandatory respondents. Fortunately, we are one of those mandatory respondents. That lets us be quite open and transparent in sharing details on how we manufacture, our supply chain, and so on. Commerce sends out a thorough questionnaire, and we finished filling it out just last week. Next they'll go through our responses and then come back with follow-up questions. As things stand right now, they're set to issue a preliminary determination by December 17th. We really can't speculate about timing. Delays are common. What's clear in this process, I think, is that this isn't the first circumvention case. Since that first 2012 AD/CVD case in China—Solar 1, which you'll recall, Amit—there have been several cases, and each time the deciding question was the wafer's country of origin. If the wafer you used was Chinese, tariffs were imposed. If it came from anywhere besides China, no tariff was imposed. That's how those earlier cases were resolved. Again, we can't say for certain how Commerce will handle this case, even though it seems fairly straightforward. This is another circumvention case. As for TOYO, our Ethiopia facility uses no Chinese wafers. All of them come from Indonesia. The polysilicon is entirely either from the U.S. or supplied by OCI in Malaysia. We will keep cooperating with the Department of Commerce, giving them any information they require, clearly in a timely fashion, and we will stay, let's just say, deeply engaged throughout that entire process. Does that address your question, Amit?

Amit Dayal analyst
#9

Yes. Thanks for clearing that up. That actually helps a lot, and it gives us something of a date to work with here too. Appreciate it. Then, regarding the 1.5 HJT capacity coming online, I believe you're indicating possible production in 1Q 2028. Should we take it that orders for the long lead-time equipment and so on have already been placed, and that work on getting that line set up is already in progress? How should we think about the CapEx being phased as that capacity is brought online?

Rhone Resch executive
#10

Sure, I'll give the first pass on that too, and if Harada-san or Simon wants to chime in as well. Yeah, the equipment for that facility is already in hand. Right now we're at the Houston plant, working our way through permitting. We need additional power, and additional water as well. I believe you've been to the site — it's 567,000 square feet, a really big facility, and there's ample space there for us to put in the 1.5 gigawatt plant; we're definitely on schedule. Amit, one thing I'd like to note regarding the company as a whole is that we've constructed cell facilities in the past, correct? Those facilities were constructed by us in Vietnam and Ethiopia, so we already possess the know-how for designing, building, and ramping up cell plants. It isn't particularly easy, as a lot of companies are discovering, yet TOYO specifically has demonstrated the ability to carry this out previously. Broadly speaking, regarding how the HJT plant will be funded, our approach is to accomplish it in a non-dilutive way to the maximum extent we can. We think the business generates enough operating cash flow. For the HJT line, we anticipate Section 45X tax credits being a significant funding source, in addition to debt financing, operating cash flow, and other non-dilutive sources. Looking ahead to that facility, it strikes me as fitting really well with the policy framework that's now in place, covering tax credits as well as the onshoring initiative. When you consider the 232 structure, our proposal to the Department of Commerce leans heavily on the HJT plant. That's all I'll say on it — if you want more detail on the HJT line, I'll let you dig in further.

Amit Dayal analyst
#11

No, that helped. Thanks. For my final question, I suppose: since you're basically pointing to full capacity utilization for 2027, how should we think about the third-party share of that utilization? What might third-party revenues look like in 2027 compared with this year?

Rhone Resch executive
#12

When you say third-party, what exactly do you mean in that context?

Amit Dayal analyst
#13

Based on the breakdown you gave...

Crocker Coulson executive
#14

Are you referring to the split between third-party and internal? Is that what you mean?

Amit Dayal analyst
#15

Yes, that's right.

Crocker Coulson executive
#16

Well, maybe — I'm not sure — Simon, are you there? Would you like to weigh in on that?

Simon Shi executive
#17

Yes.

Crocker Coulson executive
#18

Yeah.

Simon Shi executive
#19

Of course. Thank you, Amit, and I appreciate the question. Looking ahead to 2027, I'd say that essentially all of our revenue is going to come from third parties.

Amit Dayal analyst
#20

Got it.

Simon Shi executive
#21

We anticipate that every one of those shipments from... Amit, are you there?

Amit Dayal analyst
#22

I'm here.

Takahiko Onozuka executive
#23

Yes. Yes, yes. So...

Crocker Coulson executive
#24

Amit, was that a satisfactory answer to what you asked?

Amit Dayal analyst
#25

Yes, I have it. Yep.

Crocker Coulson executive
#26

Great. Operator, I believe there's another person waiting in the queue.

Phil Shen analyst
#27

Hi everyone, and thanks for the questions. I wanted to dig a bit deeper into the detention situation. Just to get a little more detail — you mentioned that shipments have been released, but could you tell us whether all of them have been released? Is anything still being held? How is the flow of materials, or cells, looking right now? If some product is still detained, what sort of timeline do you see for its release, and do you expect that eventually nothing will be detained — and if so, when might that be? Thanks.

Rhone Resch executive
#28

Sure, I'll take that. It's Rhone here. Good morning, Phil. What I'd like to do is talk a bit about CBP and the circumvention case side by side, since obviously from a supply standpoint they both feed into what we import into the U.S. As far as CBP goes, everything has been released. The volumes of cells weren't huge, but once cells start getting detained by CBP, it clearly begins to constrain your flow. We worked very closely with CBP, obviously, across a span of three, nearly four months, to secure their release, and honestly it was quite quick relative to the process CBP follows. We have a very clear and transparent channel of communication regarding our imports. We obviously have a very clean supply chain line when it comes to our polysilicon — where it's mined, who produced it. We expect CBP will keep asking questions and reviewing various import shipments from time to time, but as of right now, the CBP detentions aren't a restriction for us. Everything is released. The restriction has more to do with the uncertainty surrounding the circumvention case. Because that case is still pending out there, there's uncertainty over whether those imports from Ethiopia would face tariffs or not. We aren't bringing in cells because of that uncertainty; we're working closely with Commerce, as I mentioned. We've submitted our questionnaire, and we're in direct communication with them to try to gain some clarity on this particular case, but right now the imports aren't affected by the CBP detentions — they're more impacted by the uncertainty tied to the circumvention case.

Phil Shen analyst
#29

Great, that makes it clear for me. Thanks, Rhone. Then you guys said on your call, or in your remarks earlier, that you've got enough cells imported to cover your '27 demand. I wanted to follow up with you on this: could you sketch out what 2027 might look like financially? And then if you need to bring in additional cells, what would that be for 2028? Thanks.

Rhone Resch executive
#30

Simon, would you like to say a little about the cell supply? Our cell supply, it satisfies the commitments we have from all of our customers today. Go ahead, Simon.

Simon Shi executive
#31

You're right, Phil. In fact, what the book shows, I believe, is a fast ramp-up in prepayments and working capital, and those funds go toward supporting the shipment commitment from our Houston manufacturing next year. To put it simply in answer to your question, I think we're already targeting full operation, or close to it, next year across all of our capacity in Houston module manufacturing, and our raw material supply chain is already supporting that. We feel very confident about shipments and about our performance next year, Phil. You just brought up 2028. Hopefully, beginning in 2028, as we planned, Houston-made cells will be coming out to support our Houston module manufacturing as well.

Rhone Resch executive
#32

Also, Phil, I believe we'll have clarity regarding the circumvention case, obviously, and after that we'll be in a position to import fully from Ethiopia, correct? That's a 4 gigawatt cell line too. I think by 2028, obviously, we'll have production both domestically and more imports from our Ethiopian facility.

Phil Shen analyst
#33

Great, thanks. So I just wanted a quick update on the Commerce preliminary determination. Are you still expecting the 10th of December — sorry, December 10th — for that preliminary determination, and could you update us on where the AD/CVD timeline stands? Has anything shifted there? Thanks.

Rhone Resch executive
#34

That is, at a minimum, what statute requires them to do. We definitely expect it, and they are pushing ahead, you know, on the questionnaires and answering what we've submitted. At this stage the process tends to go back and forth, Phil; more questions will come from them, and we'll respond to those. Our expectation is that they hold to that deadline. That said, as other cases have shown us, delays do sometimes happen, and they are somewhat short-staffed. Beyond what the statute obligates them to do — which, as you noted, is December 10th — we have no clarity from them regarding any schedule.

Phil Shen analyst
#35

Understood. Thanks; so from a customer perspective, could you give us a feel for how those conversations are progressing, and how much of '27 modules or module capacity is still left that could be booked? It sounds like you're largely sold out for next year, but a rough percentage would be helpful; then could you discuss module pricing, and how that has shifted over the past two or three months since the August polysilicon 232 announcement came out? Thanks.

Simon Shi executive
#36

Phil, I'll handle this one; as we said, we have either already sold or are in the process of selling the capacity for next year out of Houston; we do keep a very limited buffer for incoming new orders, or to reflect — with pricing better reflecting market demand. To go back to your question, I believe the current order book and the current sales opportunity already fill up all our capacity for next year, but we do have, let's say, 20% — less than 20% capacity — that we reserve, even though it's already backed by the demand, or sales opportunity we see, but we aren't rushing to sign the contract at the moment. On top of that, pricing is rising with the 232 policy. We are targeting mid-30s for sales for next year, early next year, and high 30s for the remainder of next year, in terms of shipment timing.

Phil Shen analyst
#37

All right. Is that already locked in under contract? Mid-30s for the first half of next year's sales volume, and then high 30 cents per watt for the back half of next year, is that right?

Simon Shi executive
#38

Yes, that's right. Those are the orders we're currently taking, but as I said, we do keep a small portion in hand, hoping to see a better commercial opportunity down the road.

Phil Shen analyst
#39

Great, thank you. Have you begun talks about 2028, and what's the price there for an imported cell and a module made in the U.S.?

Simon Shi executive
#40

I think 2028 will reflect more of the 20, sorry, the 232 policy, which will be over 40 cents. That's the range we're discussing, all above 40 cents, 40 to 45.

Phil Shen analyst
#41

Okay, so that 40 over 40 cents — does that apply to an imported cell paired with a module made in the U.S.?

Simon Shi executive
#42

In fact, it's a mix. Essentially, at these prices, what we talk through with our customer is a blended use of cells sourced domestically and imported from abroad.

Phil Shen analyst
#43

All right. So as you scale up your Humble cell facility in '28, I would think that might even reach the mid- to high 40 cents a watt for the cell made in the U.S. and the U.S. module, right?

Simon Shi executive
#44

Yes, Phil, that's right.

Phil Shen analyst
#45

All right, thank you. So perhaps a few more questions, and after that I'll hand things over. Regarding the onshoring offset plan, what is the most recent timing for when you could hear something about a formal or official plan? The polysilicon 232 tariff takes effect on December 4th, so do you anticipate that before that date, afterward, or just a coincidence? Thank you.

Rhone Resch executive
#46

Let me take that one, Phil. From my talks with Commerce, they are putting together the guidance document for submitting plans. They anticipate it will be released this week. It was sent to the interagency last Monday, and they expect publication in the Federal Register this week. As they have no control over it at this point, it might slip a little longer, but that document would give the guidance and the structure for people to submit their plans; we have already done that, and we have had several conversations with them about exactly what our plan is, but like everyone else, we will still need to submit in the format they require. We do not anticipate it being dramatically different from what they did for pharmaceuticals, for instance. Our proposal aligns quite closely with what they are assembling at this point; no plans have been approved by them so far. They are talking with other companies. What they told us is that we are right at the front of the pack along with a couple of others, but that they likely will not approve plans much before December 4th. Approvals will keep coming through the first quarter of 2027 and beyond. Our aim here is to obtain certainty, so we will work very closely with Commerce, both once the guidance is released and more broadly with the team, to ensure they are comfortable with the structure we are using, because as we said, we are doing something a bit different as a company; we import our own cells, and we intend to onshore manufacturing in the U.S. in a fairly significant way.

Phil Shen analyst
#47

Great, thank you, Rhone. That's my final question. It concerns margins. Q3 margins came in well below what we had anticipated, at roughly 16 percent gross margin. What's your view on how they'll trend in Q4, and then how would you expect them to move as you reach higher volume across Q1, 2, and 3 of next year, if the Ethiopia case is decided in your favor? Thanks.

Simon Shi executive
#48

Oh, sure. Thanks, guys. Phil, I'll handle this one. The modest margin decline in Q3 really mirrors the mix of product categories we sell. As Rhone said, we reduced shipments from our cell factory during Q3, and that meant a larger share of total sales came from modules in Q3; that's why the overall margin level sits below where it was previously. Turning to Q4, we hope to receive preliminary results from Commerce on the circumvention matter, which would optimize our entire operation level both in Ethiopia and in the U.S. as well. It's difficult for us to comment right now. Looking ahead to 2027, as Rhone said, we have a strategy in place to address the circumvention investigation, and hopefully, if Commerce follows their proceedings on the ruling, we can fully resume operations from Ethiopia, and margin will return to near the prior level, which exceeded 20%. One more point here: even for our module manufacturing inside the U.S., in Houston, our margin is double-digit. Our module margin is double-digit too, Phil.

Crocker Coulson executive
#49

Simon, would you also like to make clear that I don’t think Q3 included any contribution from 45X, and explain how that might alter things going forward?

Simon Shi executive
#50

You're right, and those inputs are extremely helpful, Crocker. In fact, I believe there was zero contribution at any point from any 45X in Q3, whether in the Q3 margin or in the Q3 overall performance financial number. We're glad to report that our first offset tied to last year's tax credit has actually been approved. That's a meaningful step for our 45X qualification, Phil. Looking ahead, we think it will be... Rhone, please go ahead. Yeah.

Rhone Resch executive
#51

Oh, I was about to jump in there, Phil — just to pull it together, when you consider that module sales were the main driver of our margins this quarter and we're still sitting at 16.6%, and as Simon pointed out, that's double-digit margins from module production alone, without 45X in there, that shows some pretty efficient manufacturing on our part. Obviously the cells bring us bigger margins, and once those open up, as Simon pointed out, we expect our margins to increase. Just looking at the quarterly figure, I think it's important to keep in mind that we were mostly module and that those margins are strong and they don't include 45X yet. I'd call that a very successful number compared to many of the other module manufacturers.

Phil Shen analyst
#52

Great, I appreciate the detail there, guys. I'll make sure that gets passed along.

Rhone Resch executive
#53

Thank you, Phil.

Crocker Coulson executive
#54

Thank you all very much. We really appreciate that you’ve made time to be with us on today’s call. If there are any questions for management that we weren’t able to get to during today’s call, please don’t hesitate to contact me, or if you would like to meet with management at the RE+ Solar conference in Las Vegas this week, just let us know, or on their upcoming investor trips to the United States. Thanks once more, and we look forward to coming back to you to discuss the fourth quarter. That’s all, Operator.

Operator operator
#55

This concludes today's call. Thank you for attending. You may now disconnect.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete TOYO Co., Ltd. transcript - plus 131,000+ transcripts from 7,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.

Get an API key View API docs →

For developers and AI pipelines

Programmatic access to TOYO Co., Ltd. earnings transcripts and 131,000+ others is available through the EarningsAPI REST API and the hosted MCP server. Quarterly plans from $162 - full transcripts, speaker segments, full-text search, and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.